Riken Vitamin Co., Ltd. (TYO:4526)
2,825.00
+43.00 (1.55%)
May 15, 2026, 3:30 PM JST
Riken Vitamin Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 20,070 | 22,298 | 23,384 | 19,155 | 17,302 |
Cash & Short-Term Investments | 20,070 | 22,298 | 23,384 | 19,155 | 17,302 |
Cash Growth | -9.99% | -4.64% | 22.08% | 10.71% | -10.03% |
Receivables | 22,652 | 21,808 | 23,114 | 20,116 | 18,715 |
Inventory | 22,061 | 19,610 | 18,581 | 17,735 | 15,076 |
Other Current Assets | 1,444 | 1,983 | 1,442 | 1,120 | 1,697 |
Total Current Assets | 66,227 | 65,699 | 66,521 | 58,126 | 52,790 |
Property, Plant & Equipment | 27,829 | 25,525 | 23,382 | 23,637 | 25,428 |
Long-Term Investments | 20,743 | 20,175 | 27,355 | 22,338 | 23,267 |
Other Intangible Assets | 1,011 | 980 | 976 | 645 | 698 |
Long-Term Deferred Tax Assets | 576 | 619 | 540 | 475 | 474 |
Other Long-Term Assets | 1 | 1 | 2 | 2 | 2 |
Total Assets | 116,387 | 112,999 | 118,776 | 105,223 | 102,660 |
Accounts Payable | 7,822 | 7,899 | 9,900 | 8,257 | 7,696 |
Accrued Expenses | 5,548 | 5,683 | 5,618 | 4,808 | 4,656 |
Short-Term Debt | 1,941 | 3,373 | 11,938 | 3,306 | 3,674 |
Current Income Taxes Payable | 1,877 | 1,656 | 1,352 | 1,163 | 226 |
Other Current Liabilities | 2,246 | 2,518 | 2,309 | 1,390 | 1,969 |
Total Current Liabilities | 19,434 | 21,129 | 31,117 | 18,924 | 18,221 |
Long-Term Debt | 5,200 | 6,541 | 4,115 | 11,254 | 13,860 |
Pension & Post-Retirement Benefits | 294 | 292 | 297 | 230 | 209 |
Long-Term Deferred Tax Liabilities | 4,231 | 3,808 | 4,626 | 1,579 | 2,038 |
Other Long-Term Liabilities | 3,849 | 2,030 | 1,979 | 1,866 | 1,794 |
Total Liabilities | 33,008 | 33,800 | 42,134 | 33,853 | 36,122 |
Common Stock | 2,537 | 2,537 | 2,537 | 2,537 | 2,537 |
Additional Paid-In Capital | 2,466 | 2,466 | 2,466 | 2,466 | 3,072 |
Retained Earnings | 68,413 | 64,774 | 65,290 | 58,729 | 65,426 |
Treasury Stock | -3,927 | -1,952 | -7,954 | -1,633 | -13,785 |
Comprehensive Income & Other | 13,850 | 11,337 | 14,273 | 9,245 | 9,269 |
Total Common Equity | 83,339 | 79,162 | 76,612 | 71,344 | 66,519 |
Minority Interest | 40 | 37 | 30 | 26 | 19 |
Shareholders' Equity | 83,379 | 79,199 | 76,642 | 71,370 | 66,538 |
Total Liabilities & Equity | 116,387 | 112,999 | 118,776 | 105,223 | 102,660 |
Total Debt | 7,141 | 9,914 | 16,053 | 14,560 | 17,534 |
Net Cash (Debt) | 12,929 | 12,384 | 7,331 | 4,595 | -232 |
Net Cash Growth | 4.40% | 68.93% | 59.54% | - | - |
Net Cash Per Share | 437.71 | 409.01 | 224.76 | 140.07 | -7.07 |
Filing Date Shares Outstanding | 29.25 | 29.86 | 30.36 | 32.81 | 32.8 |
Total Common Shares Outstanding | 29.25 | 29.87 | 30.36 | 32.81 | 32.8 |
Working Capital | 46,793 | 44,570 | 35,404 | 39,202 | 34,569 |
Book Value Per Share | 2849.50 | 2649.91 | 2523.80 | 2174.34 | 2027.81 |
Tangible Book Value | 82,328 | 78,182 | 75,636 | 70,699 | 65,821 |
Tangible Book Value Per Share | 2814.94 | 2617.10 | 2491.65 | 2154.68 | 2006.53 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.